Global Opioid Market Forecasts 1.8% Growth Through 2034 Amid Rising Pain Management Demand and Stricter Regulations
Market Overview
The global opioid
market, valued at USD 23.70 billion in 2024, is projected
to rise to USD 28.45 billion by 2034, growing at a CAGR of 1.8%
from 2025–2034. Despite controversies linked to misuse, opioids remain
essential for treating chronic pain, cancer pain, and post-operative
recovery.
The demand for opioid analgesics reflects
the unmet need in cases where alternative therapies fail. The growing global
population suffering from chronic pain treatment requirements—such
as arthritis, lower back pain, and palliative care—ensures opioids remain
indispensable. However, governments and pharmaceutical companies are reshaping
the market with strict regulations, investment in abuse-deterrent technologies,
and greater reliance on prescription opioids under monitored frameworks.
Market Segmentation
- Product
Segmentation
- Morphine –
Widely used in cancer care.
- Oxycodone –
Popular in the U.S. for chronic pain relief.
- Hydrocodone –
Commonly prescribed for moderate-to-severe pain.
- Fentanyl –
A powerful synthetic opioid, growing in demand for severe cases.
- Application
Segmentation
- Chronic
pain treatment
- Cancer
pain treatment
- Acute
post-surgical pain
- Other
medical uses
- Distribution
Segmentation
- Hospital
pharmacies (largest share)
- Retail
pharmacies
- E-pharmacies (fastest-growing
channel)
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/opioid-market
Regional Insights
- North
America dominates due to its large base of prescription
opioids users and a well-developed healthcare system. At the same
time, policy reforms and opioid crisis management programs are reshaping
how opioids are prescribed and monitored.
- Europe follows
with structured healthcare systems ensuring controlled but steady demand.
Germany, France, and the UK remain key markets.
- Asia-Pacific is
the fastest-growing region, driven by rising healthcare expenditure,
longer life expectancy, and expanding access to pain management therapies
in emerging economies.
- Latin
America & Middle East/Africa remain in nascent stages, where
accessibility, affordability, and strict prescription controls influence
market growth.
Key Players in the Market
- Aurobindo
Pharma Limited
- Assertio
Therapeutics, Inc.
- AbbVie
Inc.
- Actavis
Plc.
- Amneal
Pharmaceuticals LLC
- Boehringer
Ingelheim International GmbH
- Cadila
Healthcare Limited
- Fresenius
Kabi
- Mallinckrodt
Pharmaceuticals
- Endo
International plc
- Johnson
& Johnson Corporation
- Lupin
Limited
- Nesher
Pharmaceuticals LLC
- Purdue
Pharma L.P.
- Pfizer
Inc.
- Rhodes
Pharmaceuticals L.P.
- Sun
Pharmaceutical Industries Limited
- Trevena
Inc.
- Teva
Pharmaceutical Industries Ltd.
Conclusion
The opioid market faces
one of the most complex landscapes in pharmaceuticals—balancing undeniable
medical benefits with the risks of misuse. While regulatory scrutiny has
reshaped prescribing trends, the market continues to expand modestly due to
rising cases of chronic pain treatment needs and the
irreplaceable role of opioid analgesics.
Looking forward, innovation in abuse-deterrent formulations,
patient monitoring technologies, and responsible use of prescription
opioids will define growth. With key companies such as Pfizer, Teva,
AbbVie, and Johnson & Johnson leading advancements, the opioid market is
positioned for sustainable expansion, reaching USD 28.45 billion by
2034.
More Trending Latest Reports By Polaris Market Research:
Active
Calcium Silicate Market
Need
for Mental Health Treatments to Drive Market Growth
Electrosurgical
Devices Market
Ambulatory
Care Services Market
Comments
Post a Comment